Journey Medical
(NASDAQ:DERM)
$3.89
0[0.00%]
Last update: 9:01AM Get Real Time Here
Q4 2023 Earnings were released on Thu Mar 21st, after the market close
The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$15.00
Lowest Price Target1
$6.00
Consensus Price Target1
$10.50

Journey Medical Stock (NASDAQ:DERM), Analyst Ratings, Price Targets, Predictions

Journey Medical Corp has a consensus price target of $10.5, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Alliance Global Partners, B. Riley Securities, and B. Riley Securities on February 16, 2024, September 7, 2023, and July 12, 2023. With an average price target of $6.83 between Alliance Global Partners, B. Riley Securities, and B. Riley Securities, there's an implied 82.22% upside for Journey Medical Corp from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Alliance Global Partners
B. Riley Securities
Cantor Fitzgerald
Roth Capital
B. Riley Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Journey Medical

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/16/2024DERMBuy Now
Journey Medical
$3.75126.67%Alliance Global Partners
Scott Henry
→ $8.5Initiates → BuyGet Alert
09/07/2023DERMBuy Now
Journey Medical
$3.7560%B. Riley Securities
Kalpit Patel
→ $6ReiteratesBuy → BuyGet Alert
07/12/2023DERMBuy Now
Journey Medical
$3.7560%B. Riley Securities
Kalpit Patel
$3 → $6MaintainsBuyGet Alert
05/23/2023DERMBuy Now
Journey Medical
$3.75-20%B. Riley Securities
Kalpit Patel
$6 → $3MaintainsBuyGet Alert
03/30/2023DERMBuy Now
Journey Medical
$3.7560%B. Riley Securities
Kalpit Patel
→ $6Reiterates → BuyGet Alert
02/25/2022DERMBuy Now
Journey Medical
$3.75140%Cantor Fitzgerald
Brandon Folkes
→ $9Initiates → OverweightGet Alert
12/16/2021DERMBuy Now
Journey Medical
$3.75300%Roth Capital
Scott Henry
Initiates → BuyGet Alert
12/07/2021DERMBuy Now
Journey Medical
$3.75273.33%B. Riley SecuritiesInitiates → BuyGet Alert

FAQ

Q

What is the target price for Journey Medical (DERM)?

A

The latest price target for Journey Medical (NASDAQ: DERM) was reported by Alliance Global Partners on February 16, 2024. The analyst firm set a price target for $8.50 expecting DERM to rise to within 12 months (a possible 118.51% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Journey Medical (DERM)?

A

The latest analyst rating for Journey Medical (NASDAQ: DERM) was provided by Alliance Global Partners, and Journey Medical initiated their buy rating.

Q

When was the last upgrade for Journey Medical (DERM)?

A

There is no last upgrade for Journey Medical.

Q

When was the last downgrade for Journey Medical (DERM)?

A

There is no last downgrade for Journey Medical.

Q

When is the next analyst rating going to be posted or updated for Journey Medical (DERM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Journey Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Journey Medical was filed on February 16, 2024 so you should expect the next rating to be made available sometime around February 16, 2025.

Q

Is the Analyst Rating Journey Medical (DERM) correct?

A

While ratings are subjective and will change, the latest Journey Medical (DERM) rating was a initiated with a price target of $0.00 to $8.50. The current price Journey Medical (DERM) is trading at is $3.89, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch